器官移植市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品、按應用、移植類型、最終用戶、地區和競爭細分

2022年，全球器官移植市場估值達到145.6億美元，預計在預測期內將大幅成長，預計年複合成長率（CAGR）為8.93%，到2028年預計將達到241.7億美元。器官移植市場主要圍繞器官移植的複雜過程。器官移植是一種醫療程序，從一個人身上提取器官並植入另一個人體內，以解決器官衰竭、彌補缺口或替換受損或缺失的器官。此手術通常用於治療肺、腎、肝等關鍵器官的器官衰竭。最常見的器官移植候選人是腦死但擁有可以挽救他人生命的健康器官的人。在開始這項複雜的程序之前，獲得患者或家人的同意至關重要，因為未經同意摘取器官被認為是非法的且在道德上是錯誤的。

主要市場促進因素

市場概況
預測期	2024-2028
2022 年市場規模	145.6億美元
2028 年市場規模	241.7億美元
2023-2028 年年複合成長率	8.93%
成長最快的細分市場	免疫抑制劑藥物
最大的市場	北美洲

1. 不斷升級的器官衰竭和器官捐贈程序：

過去十年，全球器官移植的需求穩定成長。這可歸因於重要器官衰竭發生率的增加、移植成功率的提高以及移植後結果的改善。由於飲酒、藥物濫用和不健康飲食等因素導致器官衰竭的發生率上升，導致影響肺部、腎臟和肝臟等重要器官的慢性疾病。器官移植已成為病患的救命手段，因而帶動了移植市場的擴張。此外，移植方法的技術進步正在促進市場整體收入的成長。

2. 移植器官需求激增：

全球對移植器官的需求上升可歸因於急性疾病的增加導致器官衰竭的發生率較高。例如，主要由糖尿病和高血壓等疾病引起的末期腎病變需要腎臟移植或透析作為維持患者生命的唯一治療選擇。根據美國衛生與公眾服務部的數據，2019 年美國約有 121,678 名患者等待器官移植。對解決器官衰竭的先進移植產品的巨大需求正在推動市場成長。

3. 組織庫數量不斷增加：

組織移植的需求促進了組織庫的發展，組織庫是在低溫條件下儲存生物醫學組織的實體。例如，燒傷人數的增加導致對專門用於捐贈皮膚的檢索和無菌儲存的組織庫的巨大需求。技術進步，包括冷凍保存系統和電腦化支援系統，顯著提高了組織保存的效率。這些進步使器官的儲存和檢索更加方便，從而推動了市場的成長。

4. 器官移植方法的技術進步：

3D生物列印領域的技術突破在推動器官移植的採用方面發揮關鍵作用。 PCR 技術的不斷發展，包括系統設計和先進檢測方法的改進，大大提高了組織分型的精確度和有效性。約翰霍普金斯大學醫學院開發的突破性技術稱為脫敏技術，透過允許使用任何捐贈者的器官，徹底改變了腎臟移植。此外，利用目標溫度管理的低溫治療已成為器官移植的關鍵因素，可保護心臟驟停、窒息和中風患者的神經功能。這些先進技術的引入促進了全球移植市場的成長，導致全球器官移植手術數量的增加。

主要市場挑戰

移植排斥：

移植排斥是一個複雜的過程，受體的免疫系統對移植的器官或組織發動攻擊，將其識別為外來物。三種常見類型的排斥反應包括超急性排斥反應、急性排斥反應和慢性排斥反應。儘管進行了仔細的捐贈者配對、組織分型和使用免疫抑制藥物，但移植排斥的情況仍然發生，導致器官衰竭。不遵守免疫抑制藥物治療仍是導致排斥反應的重要因素。移植排斥可能引起的併發症包括某些類型的癌症、感染、移植組織或器官的功能受損以及因藥物劑量不正確而導致的不良反應。根據器官採購和移植網路的數據，大約 4% 的死亡捐贈者腎臟移植在一年內失敗，而活體捐贈者腎臟移植受者在移植後五年內面臨 14% 的失敗率。因此，這些因素對市場的成長構成了挑戰。

器官捐贈者短缺：

根據活體腎臟捐贈者網路的數據，2017年全球腎臟移植受者人數超過9萬人，預計這數字在不久的將來還會上升。傳統上，器官是從經歷過腦損傷或中風的已故患者身上獲得的。然而，吸煙、酗酒和濫用藥物的盛行導致適合器官捐贈的健康人群減少。因此，由於可供移植的合適器官仍然有限，等待移植的患者數量不斷增加。此外，對器官捐贈缺乏認知已成為阻礙市場成長的重要因素。此外，倫理和文化的考量對移植市場構成了巨大的挑戰。發展中國家和欠已開發國家往往對器官捐贈缺乏認知，導致潛在的器官捐贈者猶豫不決。文化和社會恥辱以及宗教和習俗信仰常常阻礙家庭之間的器官捐贈。這些因素共同阻礙了市場的成長前景。

主要市場趨勢

科技與發展的進步：

技術和發展的進步透過解決該領域目前面臨的一些挑戰和限制，具有顯著增加未來器官移植需求的巨大潛力。醫學領域的技術進步和發展促進了心臟、腎臟、肝臟、肺部和各種其他器官等重要器官的移植。關鍵技術成就包括血管吻合技術的發展、透過化學免疫抑制劑有效管理免疫反應以及保存液的配製。

這些進步可以提高器官可用性、提高移植成功率並擴大移植的可能性。技術有潛力增強器官保存和運輸方法，使器官在移植前保持更長的存活時間。這可以實現更有效的器官分配、減少浪費以及更廣泛地獲得活器官。生物列印和組織工程的進步使得在實驗室中創建生物工程器官和組織成為可能。這項技術有潛力透過按需生產器官來解決器官短缺問題，減少對捐贈器官的依賴。免疫抑制藥物的發展可以帶來更有針對性和更有效的治療，從而最大限度地降低器官排斥的風險。改進的免疫抑制方案可以提高移植手術的成功率並減少對高藥物劑量的需求。異種移植（將動物的器官移植到人類身上）的研究有可能克服人類捐贈者器官的短缺。基因編輯和免疫調節的進步使異種移植變得更加可行和安全。

再生醫學的進展：

再生療法和組織工程有可能透過提供傳統供體器官的替代品來徹底改變器官移植。生物工程組織、類器官和實驗室培養器官的開發可以增加可移植組織的可用性。科學家正在實驗室中利用細胞、支架和生長因子的組合來創造功能性組織。這些生物工程組織可用於修復受損器官、恢復功能或在等待合適的捐贈器官時提供臨時支撐。類器官是實驗室中用幹細胞培育的器官的微型簡化版。它們密切模仿實際器官的結構和功能，這使得它們對於研究疾病、測試藥物反應以及未來可能用作可移植組織具有重要價值。生物工程組織和器官有可能利用患者自身的細胞來創建，從而降低排斥風險和對免疫抑制藥物的需求。

細分市場洞察

應用見解：

全球器官移植市場依應用分為器官移植和組織移植。 2022年，器官移植領域的收入佔有率最高。這可以歸因於全球器官移植需求的不斷成長，而酗酒和不健康生活方式導致器官衰竭的病例增加。此外，主要參與者和醫療保健專業人員的持續技術進步提高了成功率和移植後預後，從而推動了該領域的收入成長。另一方面，組織移植領域預計在預測期內將呈現穩定的成長速度。對角膜、骨骼、皮膚、神經、肌腱、靜脈和心臟瓣膜移植的需求很大，特別是對於遭受燒傷和事故影響的個體。

最終使用者見解：

根據最終用戶，全球移植市場分為醫院、移植中心和其他設施。醫院業務在 2021 年收入中所佔佔有率最大，主要是由於醫院進行的醫療程序和手術數量不斷增加。大多數醫院都可以方便地存取明確的器官資料庫，這有助於驗證器官供應並能夠及時進行醫療干涉。這項因素有助於醫院部門的收入成長。移植中心部門預計在預測期內將呈現穩定的收入成長率。這可以歸因於對先進醫療中心的需求不斷成長，以滿足日益成長的移植手術需求。移植中心特別適合老年人，因為它們提供個人化護理並最大限度地減少頻繁去醫院的需要。此外，在移植中心接受治療有助於降低院內感染的風險。

區域見解：

根據區域分析，2022年北美移植市場佔收入佔有率最大。該地區市場的成長得益於創新移植產品的不斷開發、發達的醫療保健系統以及個人健康支出的增加人口。此外，各種大型生物技術和醫療器材公司的強勁存在預計將進一步推動北美的收入成長。此外，加拿大和美國政府的支持性政策也促進了該地區市場的成長。預計亞太地區市場在預測期內將經歷更快的收入成長率。慢性病盛行率的不斷上升以及導致永久性器官損傷的道路事故的增加是推動該地區收入成長的主要因素。此外，該地區國家主要參與者移植技術的不斷進步有助於亞太移植市場的收入成長。同時，歐洲市場預計在預測期內將保持穩定的高收入成長率。藥物和酒精消費的增加導致器官損傷，加上主要市場參與者的強大存在和熟練醫生的可用性，正在推動該地區市場的收入成長。

目錄

第 1 章：產品概述

• 市場定義
• 市場範圍
  • 涵蓋的市場
  • 研究年份
  • 主要市場區隔

第 2 章：研究方法

• 研究目的
• 基線方法
• 主要產業夥伴
• 主要協會和二手資料來源
• 預測方法
• 數據三角測量與驗證
• 假設和限制

第 3 章：執行摘要

• 市場概況
• 主要市場細分概述
• 主要市場參與者概述
• 重點地區/國家概況
• 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球器官移植市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 依產品（組織產品、器官保存產品、移植診斷、免疫抑制藥物、其他）
  • 按應用（器官移植、組織移植）
  • 依移植類型（自體移植、同種異體移植、其他）
  • 按最終使用者（醫院、移植中心、其他）
  • 按地區
  • 按公司分類 (2022)
• 市場地圖

第 6 章：北美器官移植市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按應用
  • 按移植類型
  • 按最終用戶
  • 按國家/地區
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第 7 章：歐洲器官移植市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按應用
  • 按移植類型
  • 按最終用戶
  • 按國家/地區
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第 8 章：亞太地區器官移植市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按應用
  • 按移植類型
  • 按最終用戶
  • 按國家/地區
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第 9 章：南美洲器官移植市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按應用
  • 按移植類型
  • 按最終用戶
  • 按國家/地區
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章 ：中東和非洲器官移植市場展望

• 市場規模及預測
  • 按價值
• 市佔率及預測
  • 按產品分類
  • 按應用
  • 按移植類型
  • 按最終用戶
  • 按國家/地區
• MEA：國家分析
  • 南非器官移植
  • 沙烏地阿拉伯器官移植
  • 阿拉伯聯合大公國器官移植

第 11 章：市場動態

• 促進要素
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 併購
• 產品發布

第 13 章：全球口腔臨床營養市場：SWOT 分析

第 14 章：波特的五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 客戶的力量
• 替代產品的威脅

第15章：競爭格局

• 商業概覽
• 服務內容
• 最近的發展
• 主要人員
• SWOT分析
  • Abbvie, Inc.
  • Arthrex, Inc.
  • Zimmer Biomet
  • Medtronic plc
  • Novartis AG
  • Stryker Corporation
  • 21st Century Medicine
  • BiolifeSolutions, Inc.
  • Teva Pharmaceuticals
  • Veloxis Pharmaceutical

第 16 章：策略建議

第 17 章：關於我們與免責聲明

The Global Organ Transplant Market reached a valuation of USD 14.56 Billion in 2022 and is expected to experience substantial growth during the forecast period, with a projected Compound Annual Growth Rate (CAGR) of 8.93% and expected to reach USD 24.17 Billion through 2028. The organ transplantation market primarily revolves around the intricate process of transplanting organs. Organ transplantation is a medical procedure where an organ is extracted from one individual and implanted into another to address organ failure, bridge gaps, or replace damaged or missing organs. This procedure is commonly utilized to treat organ failure in critical organs such as the lungs, kidneys, liver, and others. The most common candidates for organ transplantation are individuals with brain death but possessing healthy organs that can potentially save another person's life. Before embarking on this complex procedure, obtaining patient or family consent is crucial, as harvesting organs without consent is considered unlawful and ethically wrong.

The organ transplant market pertains to the healthcare industry sector dedicated to the transplantation of organs and tissues from one individual (donor) to another (recipient) to replace a malfunctioning or damaged organ. Organ transplantation is a multifaceted medical procedure designed to enhance the quality of life and extend the lifespan of individuals with organ failure or specific medical conditions. The market encompasses various aspects related to organ transplantation, including organ procurement, preservation, transplantation surgery, post-operative care, and ongoing management.

Key Market Drivers

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 14.56 Billion
Market Size 2028	USD 24.17 Billion
CAGR 2023-2028	8.93%
Fastest Growing Segment	Immunosuppressant Drugs
Largest Market	North America

1. Escalating Organ Failures and Organ Donation Procedures:

Over the past decade, the demand for organ transplantation has been steadily increasing worldwide. This can be attributed to the heightened prevalence of vital organ failure, improved success rates in transplantation, and better post-transplant outcomes. The incidence of organ failure has also risen due to factors such as alcohol consumption, substance abuse, and unhealthy diets leading to chronic diseases affecting crucial organs such as the lungs, kidneys, and liver. Organ transplantations have become life-saving measures for patients, thus driving the expansion of the transplantation market. Moreover, technological advancements in transplantation methods are contributing to the overall revenue growth of the market.

2. Surge in the Demand for Transplant Organs:

The global upswing in demand for transplant organs can be attributed to the increasing occurrence of acute diseases leading to a higher prevalence of organ failures. For example, end-stage renal disease, primarily caused by conditions like diabetes and high blood pressure, necessitates kidney transplants or dialysis as the sole treatment options to sustain patient life. As per the U.S. Department of Health & Human Services, approximately 121,678 patients were awaiting organ transplants in the U.S. in 2019. This substantial demand for advanced transplantation products to address organ failure is propelling market growth.

3. Growing Number of Tissue Banks:

The need for tissue transplantation has catalyzed the growth of tissue banks, entities that store biomedical tissues under cryogenic conditions. The rise in burn injuries, for instance, has led to a significant demand for tissue banks specialized in the retrieval and aseptic storage of skin for donation. Technological advancements, including cryopreservation systems and computerized support systems, have significantly improved the efficiency of tissue preservation. These advancements are making the storage and retrieval of organs more convenient, thus fueling the market's growth.

4. Technological Advancements in Organ Transplant Methods:

Technological breakthroughs in the realm of 3D bioprinting are playing a pivotal role in driving the adoption of organ transplantation. Continuous developments in PCR techniques, including improvements in system design and advanced assays, have greatly enhanced the precision and effectiveness of tissue typing. The groundbreaking technique known as desensitization, developed by John Hopkins University School of Medicine, has revolutionized kidney transplantation by enabling the use of organs from any donor. Additionally, therapeutic hypothermia, utilizing targeted temperature management, has emerged as a critical factor in organ transplantation, safeguarding neurological functions in patients with cardiac arrest, asphyxia, and stroke. The introduction of these advanced techniques has contributed to the growth of the global transplantation market, leading to an increase in the number of organ transplant procedures worldwide.

Key Market Challenges

Transplant Rejection:

Transplant rejection is a intricate process in which the recipient's immune system launches an attack against the transplanted organ or tissue, recognizing it as foreign. Three common types of rejections include hyper-acute rejection, acute rejection, and chronic rejection. Despite careful donor matching, tissue typing, and the use of immunosuppressive medications, instances of transplant rejection still occur, resulting in organ failure. Non-compliance with immunosuppressive drugs remains a significant contributing factor to rejection. Complications that may arise from transplant rejection include certain types of cancers, infections, impaired function of the transplanted tissue or organ, and adverse effects due to incorrect medication dosages. According to the Organ Procurement and Transplantation Network, approximately 4% of deceased donor kidney transplants experience failure within one year, while living donor kidney transplant recipients face a 14% failure rate at five years post-transplant. Consequently, these factors pose challenges to the growth of the market.

Shortage of Organ Donors:

As per the Living Kidney Donors Network, the global number of kidney transplant recipients exceeded 90,000 in 2017, and this figure is projected to rise in the near future. Traditionally, organs are procured from deceased patients who have experienced brain injury or stroke. However, the prevalence of smoking, alcohol consumption, and drug abuse has led to a decline in the pool of healthy individuals suitable for organ donation. Consequently, there is a growing number of patients on transplant waiting lists, as the availability of suitable organs for transplantation remains limited. Additionally, the lack of awareness surrounding organ donation has emerged as a significant factor impeding market growth. Furthermore, ethical and cultural considerations pose substantial challenges in the transplantation market. Developing and underdeveloped nations often exhibit a lack of awareness regarding organ donation, contributing to hesitancy among potential organ donors. Cultural and social stigmas, as well as religious and customary beliefs, frequently discourage organ donation among families. These factors collectively hinder the market's growth prospects.

Key Market Trends

Advancements in Technology and Development:

Advancements in technology and development hold significant potential to substantially boost the demand for organ transplants in the future by addressing some of the challenges and limitations currently faced by the field. Technological progress and developments in the medical field have facilitated the transplantation of vital organs like the heart, kidney, liver, lungs, and various other organs. Key technical achievements encompass the development of vascular anastomosis techniques, effective management of the immune response through chemical immunosuppressants, and the formulation of preservation solutions.

These advancements can enhance organ availability, improve transplant success rates, and expand the possibilities for transplantation. Technology has the potential to enhance organ preservation and transportation methods, enabling organs to remain viable for longer periods before transplantation. This can lead to more efficient organ allocation, reduced wastage, and broader access to viable organs. Advances in bioprinting and tissue engineering are enabling the creation of bioengineered organs and tissues in the laboratory. This technology has the potential to address organ shortages by producing organs on demand, reducing the dependency on donor organs. Developments in immunosuppressive medications can lead to more targeted and effective treatments that minimize the risk of organ rejection. Improved immunosuppressive protocols can increase the success rate of transplant surgeries and reduce the need for high medication doses. Research into xenotransplantation, the transplantation of organs from animals to humans, holds the potential to overcome the shortage of human donor organs. Advances in genetic editing and immunomodulation are making xenotransplantation more feasible and safer.

Advancements in Regenerative Medicine:

Regenerative therapies and tissue engineering have the potential to revolutionize organ transplantation by providing alternatives to traditional donor organs. The development of bioengineered tissues, organoids, and lab-grown organs could increase the availability of transplantable tissues. Scientists are working on creating functional tissues in the laboratory using a combination of cells, scaffolds, and growth factors. These bioengineered tissues could be used to repair damaged organs, restore function, or provide temporary support while waiting for a suitable donor organ. Organoids are miniature, simplified versions of organs grown in the lab from stem cells. They closely mimic the structure and function of actual organs, making them valuable for studying diseases, testing drug responses, and potentially serving as transplantable tissues in the future. Bioengineered tissues and organs can potentially be created using a patient's own cells, reducing the risk of rejection and the need for immunosuppressive medications.

Segmental Insights

Application Insights:

The global organ transplant market is divided into organ transplantation and tissue transplantation based on application. The organ transplant segment accounted for the highest revenue share in 2022. This can be attributed to the increasing demand for organ transplantation worldwide, driven by a rise in cases of organ failure resulting from heavy alcohol consumption and an unhealthy lifestyle. Moreover, continuous technological advancements by key players and healthcare professionals have improved the success rate and post-transplant prognosis, thereby fueling the revenue growth of this segment. On the other hand, the tissue transplant segment is expected to exhibit a steady growth rate during the forecast period. There is a significant demand for transplants of corneas, bones, skin, nerves, tendons, veins, and heart valves, especially for individuals affected by burns and accidents.

End User Insights:

Based on end-users, the global transplantation market is categorized into hospitals, transplant centers, and other facilities. The hospital segment accounted for the largest share of revenue in 2021, primarily due to the increasing number of medical procedures and operations performed in hospitals. Most hospitals have convenient access to well-defined organ databases, which facilitates the verification of organ supply and enables prompt medical interventions. This factor contributes to the revenue growth of the hospital segment. The transplant centers segment is expected to exhibit a stable revenue growth rate during the forecast period. This can be attributed to the growing demand for advanced healthcare centers to meet the increasing need for transplantation procedures. Transplant centers are particularly suitable for older adults as they provide personalized care and minimize the need for frequent visits to hospitals. Moreover, receiving treatment in transplant centers helps reduce the risk of hospital-acquired infections.

Regional Insights:

Based on regional analysis, the transplantation market in North America accounted for the largest share of revenue in 2022. The market's growth in this region is driven by continuous development of innovative transplantation products, a well-developed healthcare system, and increased personal health expenditure by the population. Additionally, the strong presence of various large-scale biotechnology and medical device companies is expected to further drive revenue growth in North America. Moreover, supportive government policies in Canada and the US contribute to the market's growth in this region. The market in the Asia Pacific region is projected to experience a faster revenue growth rate during the forecast period. The increasing prevalence of chronic diseases and the rise in road accidents leading to permanent organ damage are major factors driving revenue growth in this region. Furthermore, continuous advancements in transplantation technology by major players in countries within this region contribute to the revenue growth of the Asia Pacific transplantation market. Meanwhile, the European market is expected to maintain a steady high revenue growth rate during the forecast period. The increasing consumption of drugs and alcohol resulting in organ damage, combined with the strong presence of major market players and availability of skilled doctors, are driving the revenue growth of the market in the region.

Key Market Players

• Abbvie, Inc.
• Arthrex, Inc.
• Zimmer Biomet
• Medtronic plc
• Novartis AG
• Stryker Corporation
• 21st Century Medicine
• BiolifeSolutions, Inc.
• Teva Pharmaceuticals
• Veloxis Pharmaceutical

Report Scope:

In this report, the Global Organ Transplant Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Organ Transplant Market, By Product:

• Tissue Products
• Organ Preservation Products
• Transplant Diagnostics
• Immunosuppressant Drugs
• Others

Organ Transplant Market, By Application:

• Organ Transplantation
• Tissue Transplantation

Organ Transplant Market, By Type of Transplant:

• Autograft
• Allograft
• Others

Organ Transplant Market, By End User:

• Hospitals
• Transplant Centers
• Others

Organ Transplant Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia-Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait
• Turkey
• Egypt

Competitive Landscape

• Company Profiles: Detailed analysis of the major companies present in the Global Organ Transplant Market.

Available Customizations:

• Global Organ Transplant market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Organ Transplant Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Tissue Products, Organ Preservation Products, Transplant Diagnostics, Immunosuppressant Drugs, Others)
  • 5.2.2. By Application (Organ Transplantation, Tissue Transplantation)
  • 5.2.3. By Type of Transplant (Autograft, Allograft, Others)
  • 5.2.4. By End User (Hospitals, Transplant Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2022)
• 5.3. Market Map

6. North America Organ Transplant Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Type of Transplant
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Organ Transplant Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Type of Transplant
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Organ Transplant Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Type of Transplant
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Organ Transplant Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Type of Transplant
      • 6.3.3.2.4. By End User

7. Europe Organ Transplant Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Type of Transplant
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Organ Transplant Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Type of Transplant
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Organ Transplant Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Type of Transplant
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Organ Transplant Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Type of Transplant
      • 7.3.3.2.4. By End User
  • 7.3.4. France Organ Transplant Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Type of Transplant
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Organ Transplant Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Type of Transplant
      • 7.3.5.2.4. By End User

8. Asia-Pacific Organ Transplant Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Type of Transplant
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Organ Transplant Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Type of Transplant
      • 8.3.1.2.4. By End User
  • 8.3.2. India Organ Transplant Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Type of Transplant
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Organ Transplant Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Type of Transplant
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Organ Transplant Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By Type of Transplant
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Organ Transplant Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By Type of Transplant
      • 8.3.5.2.4. By End User

9. South America Organ Transplant Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Type of Transplant
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Organ Transplant Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Type of Transplant
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Organ Transplant Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Type of Transplant
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Organ Transplant Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Type of Transplant
      • 9.3.3.2.4. By End User

10. Middle East and Africa Organ Transplant Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Type of Transplant
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Organ Transplant Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Type of Transplant
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Organ Transplant Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Type of Transplant
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Organ Transplant Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Type of Transplant
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global Oral Clinical Nutrition Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Service Offerings
• 15.3. Recent Developments
• 15.4. Key Personnel
• 15.5. SWOT Analysis
  • 15.5.1. Abbvie, Inc.
  • 15.5.2. Arthrex, Inc.
  • 15.5.3. Zimmer Biomet
  • 15.5.4. Medtronic plc
  • 15.5.5. Novartis AG
  • 15.5.6. Stryker Corporation
  • 15.5.7. 21st Century Medicine
  • 15.5.8. BiolifeSolutions, Inc.
  • 15.5.9. Teva Pharmaceuticals
  • 15.5.10. Veloxis Pharmaceutical

16. Strategic Recommendations

17. About Us & Disclaimer